Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans

Clinical and Experimental Immunology

Volumn 118, Issue 2, 1999, Pages 235-241

  Bruunsgaard, Helle ^c,d   Pedersen, A N ^a   Schroll, M ^b   Skinhoj P ^c   Pedersen, B K ^c  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b H:S Kommunehospitalet ^*  (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Ageing; IL 1 ; IL 6; Lipopolysaccharide; Tumour necrosis factor alpha

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ARTICLE; BODY MASS; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; HUMAN TISSUE; INFECTION RESISTANCE; PRIORITY JOURNAL; SEPSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; BODY MASS INDEX; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032707321     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01045.x     Document Type: Article

References (55)

1. 1 Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen BK. A high plasma concentration of TNF-alfa is associated with dementia in centenarians. J Gerontol Med Scien 1999; 57A:357-64.
2. 2 Paolisso G, Rizzo MR, Mazziotti G et al. Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol, Endocrinol, Metabol 1998; 38:E294-E299.
3. 3 Wei J, Xu H, Davies JL, Hemmings GP. Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci 1992; 51:1953-6.
4. 4 Kania DM, Binkley N, Checovich M, Havighurst T, Schilling M, Ershler WB. Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J Am Geriatr Soc 1995; 43:236-9.
5. 5 Ershler WB, Sun WH, Binkley N et al. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymph Cytokine Res 1993; 12:225-30.
6. 6 Hager K, Machein U, Krieger S, Platt D, Seefried G, Bauer J. Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging 1994; 15:771-2.
7. 7 James K, Premchand N, Skibinska A, Skibinski G, Nicol M, Mason JI. IL-6, DHEA and the ageing process. Mech Ageing Dev 1997; 93:15-24.
8. 8 Baggio G, Donazzan S, Monti D et al. Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors. FASEB J 1998; 12:433-7.
9. 9 Catania A, Airaghi L, Motta P et al. Cytokine antagonists in aged subjects and their relation with cellular immunity. J Gerontol Med Sci 1997; 52:B93-B97.
10. 10 Ballou SP, Lozanski FB, Hodder S et al. Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Ageing 1996; 25:224-30.
11. 11 Caswell M, Pike LA, Bull BS, Stuart J. Effect of patient age on tests of the acute-phase response. Arch Pathol Lab Med 1993; 117:906-10.
12. 12 Gleckman R, Hibert D. Afebrile bacteremia. A phenomenon in geriatric patients. JAMA 1982; 248:1478-81.
13. 13 Torres JM, Cardenas O, Vasquez A, Schlossberg D. Streptococcus pneumoniae bacteremia in a Community Hospital. Chest 1998; 113:387-90.
14. 14 Finkelstein MS, Petkun WM, Freedman ML, Antopol SC. Pneumococcal bacteremia in adults: age-dependent differences in presentation and in outcome. J Am Geriatr Soc 1983; 31:19-27.
15. 15 Ahkee S, Srinath L, Ramirez J. Community-acquired pneumonia in the elderly: association of mortality with lack of fever and leukocytosis. South Med J 1997; 90:296-8.
16. 16 Miller RA. The aging immune system: primer and prospectus. Science 1996; 273:70-74.
17. 17 Jarrett RJ, Shipley MJ, Rose G. Weight and mortality in the Whitehall Study. Br Med J Clin Res Ed 1982; 285:535-7.
18. 18 Tayhack M, Kumanyika S, Chee E. Body weight as a risk factor in the elderly. Arch Intern Med 1990; 150:1065-72.
19. 19 Losonezy KG, Harris TB, Cornoni HJ et al. Does weight loss from middle age to old age explain the inverse weight mortality relation in old age.V Am J Epidemiol 1995; 141:312-21.
20. 20 Jaattela M. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. Lab Invest 1991; 64:724-42.
21. 21 Gutierrez-Ramos JC, Bluethmann H. Molecules and mechanisms operating in septic shock: lessons from knockout mice. Immunol Today 1998; 18:329-34.
22. 22 Schroll M, Jorgensen T, Ingerslev J. The Glostrup Population Studies, 1964-92. Dan Med Bull 1992; 39:204-7.
23. 23 Schroll M, Avlund K, Davidsen M. Predictors of five-year functional ability in a longitudinal survey of men and women aged 75-80. The 1914 population in Glostrup, Denmark. Aging Mila 1997; 9:143-52.
24. 24 Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 1982; 91:686-93.
25. 25 Zheng ZJ, Sharrett AR, Chambless LE et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and pre-clinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997; 131:115-25.
26. 26 Postiglione A, Cicerano U, Gallotta G et al. Prevalence of peripheral arterial disease and related risk factors in elderly institutionalized subjects. Gerontol 1992; 38:330-7.
27. 27 Newman AB, Siscovick DS, Manolio TA at al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993; 88:837-45.
28. 28 McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991; 87:119-28.
29. 29 Criqui MH, Coughlin SS, Fronek A. Noninvasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study. Circulation 1985; 72:768-73.
30. 30 Ligthart GJ, Corberand JX, Fournier C et al. Admission criteria for immunogerontological studies in man; the SENIEUR protocol. Mech Ageing Dev 1984; 28:47-55.
31. 31 Gon Y, Hashimoto S, Hayashi S, Koura T, Matsumoto K, Horie T. Lower serum concentrations of cytokines in elderly patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. Clin Exp Immunol 1996; 106:120-6.
32. 32 Rudd AG, Banerjee DK. Interleukin-1 production by human monocytes in ageing and disease. Age Ageing 1989; 18:43-46.
33. 33 McLachlan JA, Serkin CD, Morrey KM, Bakouche O. Antitumoral properties of aged human monocytes. J Immunol 1995; 154:832-43.
34. 34 Bruley RM, Vergnon I. Interleukin-1 synthesis and activity in aged mice. Mech Ageing Dev 1984; 24:247-64.
35. 35 Effros RB, Svoboda K, Walford RL. Influence of age and calorie restriction on macrophage IL-6 and TNF production. Lymphokine Cytokine Res 1991; 10:347-51.
36. 36 Bradley SF, Vibhagool A, Kunkel SL, Kauffman CA. Monokine secretion in aging and protein malnutrition. J Leuk Biol 1989; 45:510-4.
37. 37 Wallace PK, Eisenstein TK, Meissler JJJ, Morahan PS. Decreases in macrophage mediated antitumor activity with aging. Mech Ageing Dev 1995; 77:169-84.
38. 38 Davila DR, Edwards CK, Arkins S, Simon J, Kelley KW. Interferon-gamma-induced priming for secretion of superoxide anion and tumor necrosis factor-alpha declines in macrophages from aged rats. FASEB J 1990; 4:2906-11.
39. 39 Inamizu T, Chang MP, Makinodan T. Influence of age on the production and regulation of interleukin-1 in mice. Immunology 1985; 55:447-55.
40. 40 Norman DC, Castle S, Yamamura RH, Yoshikawa TT. Interrelationship of fever, immune response and aging in mice. Mech Ageing Dev 1995; 80:53-67.
41. 41 Riancho JA, Zarrabeitia MT, Amado JA, Olmos JM, Gonzalez MI. Age-related differences in cytokine secretion. Gerontol 1994; 40:8-12.
42. 42 Born J, Uthgenannt D, Dodt C et al. Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep. Mech Ageing Dev 1995; 84:113-26.
43. 43 Roubenoff R, Harris TB, Abad LW, Wilson PF, Dallal GE, Dinarello CA. Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol Med Scien 1998; 53:M20-M26.
44. 44 Fagiolo U, Cossarizza A, Santacaterina S et al. Increased cytokine production by peripheral blood mononuclear cells from healthy elderly people. Ann N Y Acad Sci 1992; 663:490-3.
45. 45 Desch CE, Kovach NL, Present W, Broyles C, Harlan JM. Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res 1989; 8:141-6.
46. 46 Pacifici R, Brown C, Puscheck E, et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 1991; 88:5134-8.
47. 47 Li ZG, Danis VA, Brooks PM. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 1993; 11:157-62.
48. 48 Angstwurm MW, Gartner R, Ziegler HII. Cyclic plasma IL-6 levels during normal menstrual cycle. Cytokine 1997; 9:370-4.
49. 49 Kanda N, Tsuchida T, Tamaki K. Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin Exp Immunol 1996; 106:410-5.
50. 50 Fricker PA, Gleeson M, McDonald WA, Pyne DR, Flanagan A, Clancy RL. Incidence of respiratory and gut infections in elite swimmers. International Society of Exercise and Immunology 1999; IV. International Symposium, Rome: 67 (Abstr.).
51. 51 Van Dissel JT, Van Langevelde P, Westendorp RGJ, Kvappenberg K, Frölich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998; 351:950-3.
52. 52 Westendorp RGJ, Langermans JAM, de Bel CE et al. Release of tumor necrosis factor: an innate host characteristic that may contribute to the outcome of meningococcal disease. J Infect Dis 1995; 171:1057-60.
53. 53 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-9.
54. 54 De GD, Zangerle PF, Gevaert Y et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992; 4:239-48.
55. 55 DeForge LE, Remick DG. Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem Biophys Res Commun 1991; 174:18-24.